Warning: The NCBI web site requires JavaScript to function. more...
Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW.
Breast Cancer Res. 2006;8(1):R11. Epub 2006 Feb 17.
Related citations
Menopausal hormone therapy and risk of clinical breast cancer subtypes.
Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. Epub 2009 Mar 31.
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R.
Cancer. 2002 Dec 15;95(12):2455-64.
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR.
JAMA. 2003 Jun 25;289(24):3254-63.
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Li CI, Weiss NS, Stanford JL, Daling JR.
Cancer. 2000 Jun 1;88(11):2570-7.
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States).
Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR.
Cancer Causes Control. 2003 Apr;14(3):225-33.
Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R.
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):946-54.
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR.
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):43-50. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2803.
Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.
Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R.
J Natl Cancer Inst. 2010 Sep 22;102(18):1422-31. Epub 2010 Aug 23.
Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.
Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR.
Int J Cancer. 2003 Nov 20;107(4):647-51.
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS.
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1643-54. Epub 2010 May 25.
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM, Morrow M, Sellers TA.
JAMA. 1999 Jun 9;281(22):2091-7.
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ.
Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600.
The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age.
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1061-6.
Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
Reeves GK, Beral V, Green J, Gathani T, Bull D; Million Women Study Collaborators.
Lancet Oncol. 2006 Nov;7(11):910-8.
Hormone replacement therapy in relation to breast cancer.
Chen CL, Weiss NS, Newcomb P, Barlow W, White E.
JAMA. 2002 Feb 13;287(6):734-41.
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA.
Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):297-301.
Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E.
Arch Gynecol Obstet. 2008 Nov;278(5):443-9. Epub 2008 Mar 12.
Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI, Anderson BO, Daling JR, Moe RE.
JAMA. 2003 Mar 19;289(11):1421-4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on